| Literature DB >> 15979203 |
Hein P Stallmann1, Chris Faber, Antonius L J J Bronckers, Jolanda M A de Blieck-Hogervorst, Carlo P J M Brouwer, Arie V Nieuw Amerongen, Paul I J M Wuisman.
Abstract
In order to analyze the clinical potential of two antimicrobial peptides, human lactoferrin 1-11 (hLF1-11) and synthetic histatin analogue Dhvar-5, we measured the killing effect on bacteria, and the potential toxicity on erythrocytes and bone cells. The antimicrobial activity was determined in a killing assay on six strains, including methicillin resistant Staphylococcus Aureus. The effect on human erythrocytes and MC3T3 mouse bone cells was measured with a hemolysis assay and a viability assay, respectively. Both hLF1-11 and Dhvar-5 dose-dependently killed all bacterial strains, starting at concentrations of 6 microg/mL. hLF1-11 had no effect on mammalian cells at concentrations up to 400 microg/mL, but Dhvar-5 induced significant hemolysis (37% at 200 microg/mL) and bone cell death (70% at 400 microg/mL). This indicates that both peptides are able to kill various resistant and non-resistant bacteria, but Dhvar-5 may exert a cytotoxic effect on host cells at higher concentrations.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15979203 DOI： 10.1016/j.peptides.2005.05.014
Source DB: PubMed Journal: Peptides ISSN： 0196-9781 Impact factor: 3.750